Literature DB >> 16053508

Regulation of cancer cell motility through actin reorganization.

Daisuke Yamazaki1, Shusaku Kurisu, Tadaomi Takenawa.   

Abstract

Cell migration is a critical step in tumor invasion and metastasis, and regulation of this process will lead to appropriate therapies for treating cancer. Cancer cells migrate in various ways, according to cell type and degree of differentiation. The different types of cell migration are regulated by different mechanisms. Reorganization of the actin cytoskeleton is the primary mechanism of cell motility and is essential for most types of cell migration. Actin reorganization is regulated by Rho family small GTPases such as Rho, Rac, and Cdc42. These small GTPases transmit extracellular chemotactic signals to downstream effectors. Of these downstream effectors, Wiskott-Aldrich syndrome protein (WASP) family proteins are key regulators of cell migration. Activated WASP family proteins induce the formation of protrusive membrane structures involved in cell migration and degradation of the extracellular matrix. Inhibition of Rho family small GTPase signaling suppresses the migration and invasion of cancer cells. Thus, control of cell migration via the actin cytoskeleton provides the possibility of regulating cancer cell invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16053508     DOI: 10.1111/j.1349-7006.2005.00062.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  229 in total

Review 1.  Role of MTA2 in human cancer.

Authors:  Kyle R Covington; Suzanne A W Fuqua
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

2.  Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells.

Authors:  Chuu-Yun A Wong; Hada Wuriyanghan; Yan Xie; Ming-Fong Lin; Peter W Abel; Yaping Tu
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

3.  Developmental expression of Drosophila Wiskott-Aldrich Syndrome family proteins.

Authors:  Evelyn Rodriguez-Mesa; Maria Teresa Abreu-Blanco; Alicia E Rosales-Nieves; Susan M Parkhurst
Journal:  Dev Dyn       Date:  2012-01-31       Impact factor: 3.780

4.  Spatio-temporal development of the endothelial glycocalyx layer and its mechanical property in vitro.

Authors:  Ke Bai; Wen Wang
Journal:  J R Soc Interface       Date:  2012-03-14       Impact factor: 4.118

5.  Protein fluxes along the filopodium as a framework for understanding the growth-retraction dynamics: the interplay between diffusion and active transport.

Authors:  Pavel I Zhuravlev; Garegin A Papoian
Journal:  Cell Adh Migr       Date:  2011 Sep-Oct       Impact factor: 3.405

6.  Mapping the cytoskeletal prestress.

Authors:  Chan Young Park; Dhananjay Tambe; Adriano M Alencar; Xavier Trepat; En Hua Zhou; Emil Millet; James P Butler; Jeffrey J Fredberg
Journal:  Am J Physiol Cell Physiol       Date:  2010-02-17       Impact factor: 4.249

7.  WNT5A expression in ameloblastoma and its roles in regulating enamel epithelium tumorigenic behaviors.

Authors:  Waleerat Sukarawan; Darrin Simmons; Cynthia Suggs; Kimberly Long; J Timothy Wright
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer.

Authors:  Tracey A Martin; Gordon Pereira; Gareth Watkins; Robert E Mansel; Wen G Jiang
Journal:  Clin Exp Metastasis       Date:  2007-11-06       Impact factor: 5.150

9.  Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor.

Authors:  Kyung Hee Lee; Jae Ryong Kim
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

10.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.